360Dx Cancer Bulletin: Myriad Genetics Betting on Hereditary Cancer, Prenatal Testing Businesses for Continued Future Growth

Premium

Cancer Bulletin In-Depth Reporting From The 360Dx Newsroom

Enjoying 360Dx? Tell a Friend!  Help us spread the word about 360Dx! Refer a friend or colleague and we'll give your team free access to 360Dx Premium for three months! Contact customerservice@360Dx.com for more details. Recent Premium Articles   Myriad Genetics Betting on Hereditary Cancer, Prenatal Testing Businesses for Continued Future Growth Published on Feb 06, 2019   Metabolism-Based Liquid Biopsy Tool Being Developed by Elypta for Recurrent Renal Cell Cancer Published on Feb 06, 2019   Diatech Pharmacogenetics Explores Long DNA as Biomarker of Colorectal Cancer in Stool Published on Feb 04, 2019   Aggressive Prostate Cancer Test Targeted by UK Researchers for Early Detection Published on Feb 04, 2019   Clinical Utility of Polygenic Risk Scores Questioned in Commentary Published on Feb 04, 2019   Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making Published on Feb 01, 2019   NGS-Based Lung Cancer Profiling Used Routinely by Heidelberg Research Team Published on Jan 31, 2019   OncoCyte Readies Lung Cancer Test for Launch, Previews New Platform Validation Data Published on Jan 30, 2019 Recent Free Articles   OptraScan, Neuberg Diagnostics Partner on Digital Pathology Services for India, Middle East, Africa Published on Feb 05, 2019   Japanese Regulators Approve Promega CDx for Merck's Keytruda Published on Feb 05, 2019   Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department Published on Feb 05, 2019   Sienna Diagnostics Inks Singapore Distribution Deal for Bladder Cancer Test Published on Feb 04, 2019   Liquid Biopsy Platform Developer Elypta Receives €2.35M in EU Funding Published on Feb 04, 2019   Healthcare Stakeholders Ask CMS Not to Limit Access to NGS Hereditary Cancer Risk Tests Published on Feb 01, 2019   Opko Health Receives FDA Approval for Sangia Point-of-Care PSA Test Published on Feb 01, 2019   NCCN Updates Prostate Cancer Early Detection Guidelines With Biomarker Information Published on Feb 01, 2019   Novitas Announces Future Non-Coverage of Opko's 4Kscore Prostate Cancer Test Published on Feb 01, 2019 The Pressing Need for Validation and Proficiency Testing Reference Samples to Enable Objective Review of NGS Laboratory Performance This webinar from SeraCare discusses what laboratorians must consider to ensure their NGS assays are thoroughly validated; their labs inspection-ready; and their results accurate and reproducible. Download it from GenomeWeb’s library Recommended for You   Israel's BATM to Invest up to $30M in Ador Diagnostics Published on Jan 28, 2019 premium   Alzheimer's Test From NIAID Detects Early Formation of Tau Aggregates to Aid Diagnosis Published on Jan 09, 2019 Quality Control Practices for Massively Parallel Sequencing of Tumors This webinar from SeraCare presents that with NGS assays steadily demonstrating greater clinical utility, NGS QC and standardization are more important than ever. Download it from GenomeWeb’s library Job listings Senior Precision Oncology Field Specialist Company: Strata Oncology Location: Ann Arbor MI Apply now Field Application Scientist Company: Asuragen Location: Austin TX Apply now Medical Genetics Curator, Genetic Counselor Company: Computercraft Corporation Location: Bethesda MD Apply now Production Scientist II Company: Asuragen Location: Austin TX Apply now NGS QC Solutions: Reviewing & Reporting Data In this webinar series from SeraCare learn how to use management solutions to address assay validation, training, troubleshooting, NGS QC metrics review, and NGS QC metrics reporting. Download it from GenomeWeb’s library